Skip to main content
Log in

Terlipressin stems cash flow in bleeding oesophageal varices

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Wechowski JG, Tetlow AP, McEwan P, Woehl A, Currie CJ.Cost-utility analysis in a UK setting of vasoactive drug treatments in acute bleeding oesophageal varices in cirrhotic patients - a discrete event simulation model. Value in Health 9: A190 (plus oral presentation) abstr. G13, No. 6, Nov-Dec 2006

  2. Garcia-Contreras F, Constantino-Casas P, Nevarez-Sida A, Del Angel-García G, García-Constantino M, Rojas-Martínez E.Economic evaluation of the pharmacological therapy of bleeding esophageal varices in Mexico. Value in Health 9: A244 (plus poster) abstr. PG111, No. 6, Nov-Dec 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terlipressin stems cash flow in bleeding oesophageal varices. Pharmacoecon. Outcomes News 516, 5 (2006). https://doi.org/10.2165/00151234-200605160-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605160-00007

Keywords

Navigation